With the introduction of INSUMAN®, a leading human insulin product from Sanofi’s range of diabetes treatments, Sanofi Nigeria is now the only company to provide a full range of both oral and injectable treatments for patients with diabetes in Nigeria.
To better support the patients in the mana
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
BusinessDay
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
